Key facts
- This page summarizes Jason Coloma V's Form 3 filing for Braveheart Bio, Inc. (BRVE).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2026, 21:07.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose.
SEC remarks
Exhibit 24 - Power of Attorney